Home
LyncMed

LyncMed Market Share Analysis for May 2026

Business and Consumer Services > Business Services

Domainlyncmed.com

Year Founded2015

Employees51 - 200

Annual Revenue$5M - $10M

LyncMed

LyncMed (including company regionals)

lyncmed.com

See more website traffic and engagement information

LyncMed Revenue up to May 2026 is 5M - 10M

revenue generated by LyncMed top domains

LyncMed top domains revenue over 3 years

Revenue for LyncMed top domains

lyncmed.com5M - 10M

See more with Sales Intelligence

Total visits to LyncMed's top domains

Understand LyncMed market share and potential market reach.

Total visits last 3 months

No Data to Display

Avg. visit duration in LyncMed's top domains

Analyze LyncMed engagement metrics.

Average visit duration last 3 months

No Data to Display

Avg. pageviews on LyncMed's top domains

See how LyncMed keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

No Data to Display

LyncMed top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by LyncMed

These are the website technologies, by industry, used by LyncMed top domains

Payment & Currencies (2)

Cart Functionality

Conversion & Analytics (1)

Google Analytics

Customer Communication (1)

Zendesk

Feedback and Surveys (1)

Zendesk Embeddables

More Technologies

4

See all

News & Signals from LyncMed

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsNextSmartShip Inc. partners with Lyncmed.NextSmartShip, a world-leading fulfillment service provider for global e-commerce sellers, signed a strategic partnership agreement with LyncMed, a major global B2B e-commerce platform for medical instruments.

NewsLyncmed received financing of $20M in series B+1 round of financing on May 23rd '19.Chinese medical device e-commerce platform LyncMed announced on Thursday that it has raised US$20 million in a series B+1 round of financing led by VisionMax Health Fund (VHF).